Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1967 May;46(5):746–752. doi: 10.1172/JCI105575

Thyrocalcitonin, EGTA, and Urinary Electrolyte Excretion*

Howard Rasmussen 1,2,†, Constantine Anast 1,2, Claude Arnaud 1,2
PMCID: PMC297077  PMID: 6025480

Abstract

The infusion of thyrocalcitonin (TCT) into thyroparathyroidectomized rats, given either no exogenous parathyroid hormone or a constant infusion of this hormone, leads to a transient phosphaturia and a decreased excretion of urinary magnesium, calcium, and hydroxyproline without a change in glomerular filtration rate. The changes in phosphate excretion may be due to a direct effect of the hormone upon renal tubular function or they may be a consequence of the fall in plasma calcium brought about by the action of TCT upon bone. In support of this latter alternative is the fact that the infusion of sodium ethylenebis-oxyethylenenitrilotetraäcetic acid (EGTA, a specific chelator of calcium) also leads to phosphaturia presumably as a consequence of hypocalcemia. However, EGTA infusion leads to enhanced urinary hydroxyproline excretion and sustained phosphaturia. These latter observations are interpreted to mean that alterations in the local ionic environment of osteolytic cells lead to changes in their activity and constitute a local regulatory system whose activity is modulated by the hormones, thyrocalcitonin and parathyroid hormone.

Full text

PDF
752

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anast C., Arnaud C. D., Rasmussen H., Tenenhouse A. Thyrocalcitonin and the response to parathyroid hormone. J Clin Invest. 1967 Jan;46(1):57–64. doi: 10.1172/JCI105511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arnaud C., Rasmussen H., Anast C. Further studies on the interrelationship between parathyroid hormone and vitamin D. J Clin Invest. 1966 Dec;45(12):1955–1964. doi: 10.1172/JCI105500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BAGHDIANTZ A., FOSTER G. V., EDWARDS A., KUMAR M. A., SLACK E., SOLIMAN H. A., MACINTYRE I. EXTRACTION AND PURIFICATION OF CALCITONIN. Nature. 1964 Sep 5;203:1027–1028. doi: 10.1038/2031027a0. [DOI] [PubMed] [Google Scholar]
  4. Barnicot N. A. The local action of the parathyroid and other tissues on bone in intracerebral grafts. J Anat. 1948 Oct;82(Pt 4):233–248.2. [PMC free article] [PubMed] [Google Scholar]
  5. Bronner F., Aubert J. P. Bone metabolism and regulation of the blood calcium level in rats. Am J Physiol. 1965 Nov;209(5):887–890. doi: 10.1152/ajplegacy.1965.209.5.887. [DOI] [PubMed] [Google Scholar]
  6. DENT C. E. Some problems of hyperparathyroidism. Br Med J. 1962 Dec 8;2(5318):1495–1500. doi: 10.1136/bmj.2.5318.1495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Estep H. L., Gardner C. T., Jr, Taylor J. P., Minott A., Tucker H. S., Jr Phosphate excretion patterns following intravenous injection of ethylenediaminetetraacetate (EDTA). J Clin Endocrinol Metab. 1965 Oct;25(10):1385–1392. doi: 10.1210/jcem-25-10-1385. [DOI] [PubMed] [Google Scholar]
  8. FOSTER G. V., BAGHDIANTZ A., KUMAR M. A., SLACK E., SOLIMAN H. A., MACINTYRE I. THYROID ORIGIN OF CALCITONIN. Nature. 1964 Jun 27;202:1303–1305. doi: 10.1038/2021303a0. [DOI] [PubMed] [Google Scholar]
  9. Friedman J., Raisz L. G. Thyrocalcitonin: inhibitor of bone resorption in tissue culture. Science. 1965 Dec 10;150(3702):1465–1467. doi: 10.1126/science.150.3702.1465. [DOI] [PubMed] [Google Scholar]
  10. HIRSCH P. F., GAUTHIER G. F., MUNSON P. L. THYROID HYPOCALCEMIC PRINCIPLE AND RECURRENT LARYNGEAL NERVE INJURY AS FACTORS AFFECTING THE RESPONSE TO PARATHYROIDECTOMY IN RATS. Endocrinology. 1963 Aug;73:244–252. doi: 10.1210/endo-73-2-244. [DOI] [PubMed] [Google Scholar]
  11. HIRSCH P. F., VOELKEL E. F., MUNSON P. L. THYROCALCITONIN: HYPOCALCEMIC HYPOPHOSPHATEMIC PRINCIPLE OF THE THYROID GLAND. Science. 1964 Oct 16;146(3642):412–413. doi: 10.1126/science.146.3642.412. [DOI] [PubMed] [Google Scholar]
  12. Harris E. D., Jr, Sjoerdsma A. Effect of parathyroid extract on collagen metabolism. J Clin Endocrinol Metab. 1966 Mar;26(3):358–359. doi: 10.1210/jcem-26-3-358. [DOI] [PubMed] [Google Scholar]
  13. Lavender A. R., Pullman T. N. Changes in inorganic phosphate excretion induced by renal arterial infusion of calcium. Am J Physiol. 1963 Nov;205(5):1025–1032. doi: 10.1152/ajplegacy.1963.205.5.1025. [DOI] [PubMed] [Google Scholar]
  14. PROCKOP D. J., UDENFRIEND S. A specific method for the analysis of hydroxyproline in tissues and urine. Anal Biochem. 1960 Nov;1:228–239. doi: 10.1016/0003-2697(60)90050-6. [DOI] [PubMed] [Google Scholar]
  15. RAISZ L. G. BONE RESORPTION IN TISSUE CULTURE. FACTORS INFLUENCING THE RESPONSE TO PARATHYROID HORMONE. J Clin Invest. 1965 Jan;44:103–116. doi: 10.1172/JCI105117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Robinson C. J., Martin T. J., MacIntyre I. Phosphaturic effect of thyrocalcitonin. Lancet. 1966 Jul 9;2(7454):83–84. doi: 10.1016/s0140-6736(66)91807-1. [DOI] [PubMed] [Google Scholar]
  17. TALMAGE R. V., NEUENSCHWANDER J., KRAINTZ L. EVIDENCE FOR THE EXISTENCE OF THYROCALCITONIN IN THE RAT. Endocrinology. 1965 Jan;76:103–107. doi: 10.1210/endo-76-1-103. [DOI] [PubMed] [Google Scholar]
  18. TENENHOUSE A., ARNAUD C., RASMUSSEN H. THE ISOLATION AND CHARACTERIZATION OF THYROCALCITONIN. Proc Natl Acad Sci U S A. 1965 Apr;53:818–822. doi: 10.1073/pnas.53.4.818. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES